Celltrion launches FDA-approved AVTOZMA IV biosimilar in U.S.
AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA.
Celltrion
AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA.